Olinvacimab (TTAC-0001) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab has antiangiogenic activity. Olinvacimab can be used for the research of recurrent glioblastoma and breast cancer.
Purity:
>95.0%
CAS Number:
[2095504-49-5]
Target:
VEGFR/PDGFR
* VAT and and shipping costs not included. Errors and price changes excepted